Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis.
about
APC-derived cytokines and T cell polarization in autoimmune inflammationNLRP3 Inflammasome in Neurological Diseases, from Functions to TherapiesNLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.Interleukin 18 in the CNS.Deregulated inflammasome signaling in disease.Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling.Complementing the inflammasome.Inflammasomes and autoimmunityInflammasome activation in obesity-related inflammatory diseases and autoimmunity.Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patientsInterferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.NLRP3 Inflammasome and MS/EAE.NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotypeInterferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis.How do immune cells overcome the blood-brain barrier in multiple sclerosis?Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases.The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes.Initial immunopathogenesis of multiple sclerosis: innate immune response.Licensing Adaptive Immunity by NOD-Like Receptors.Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).Transcriptomic Analyses Reveal Differential Gene Expression of Immune and Cell Death Pathways in the Brains of Mice Infected with West Nile Virus and Chikungunya Virus.Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis.How inflammasomes inform adaptive immunity.Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice.Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma.Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts.Differential contribution of microglia and monocytes in neurodegenerative diseases.NLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis.Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.Inflammasome Proteins As Biomarkers of Multiple Sclerosis.Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis.
P2860
Q24679426-130C3ECF-6EF2-4F18-9C72-058886F4161BQ29248417-31EBC8FF-915C-44C1-A75E-B8AB676FB740Q30519470-A6062236-6B9E-4323-B379-08FA14E2AAA4Q34095673-02DA78C3-DBA2-4BE2-99FA-5D84894F325DQ34212591-D7AF059C-88B3-4668-BE42-CF59822672E0Q34328201-8A70F52B-CD43-4980-BA17-0167D1A03D31Q34501875-2D67E71E-210B-4CB8-BBCB-2FAD9FDEA69EQ34670542-6D54D0DC-F588-4BD0-9A50-72CDE73C6D13Q34701729-3DDC647A-765A-45CD-8846-A0D6143D64D7Q36091339-5F0486EB-4997-494F-83D9-1C17C349F576Q36431053-A230F31A-75FB-40DD-A6A7-08D8676624E2Q36566053-EA761E73-B5B8-45DB-B938-FD955115D8A2Q36670359-2816EDB8-23EC-4D69-90A3-C500D0A13C2CQ37301528-8A319A9C-3B33-42DD-90A8-78BD3C1E0B99Q37348839-C853AC9B-1D33-423E-873A-4B2D07698032Q37729175-C449CFA5-A3A2-491C-851F-6109C4168017Q37873072-CA9F4A12-C62E-4DCA-B201-2E937AA555F0Q37954043-2B191EC2-3107-4C26-A04B-EEF152BD5B9EQ38077590-508B1429-9FEB-4E17-A959-4FC1B410A0CEQ38156767-7E3937FF-93E0-4F6C-AFF2-899C628B9D24Q38177270-29E9F1BC-9AC0-49C6-99C3-7D8C75D85D06Q38687394-75C01B53-ECFF-4AA0-9100-8CAAF71A18F4Q39044498-41ECA694-22DD-4CE6-8344-211589AF2C6AQ40061942-D6840F6C-55F7-472A-9863-3AB5BD88FCE2Q40085017-98927BE0-9DE6-449F-8377-7BA727B759BCQ41990044-24314AFE-A8A8-40FA-9579-CBBD2182BFCBQ43173955-07EAE028-1DFB-402C-B0F3-B95DF416EAA1Q46279808-B0C013B1-C9B3-47D3-A2E3-405061A2BBB3Q46572704-5B7DA5F2-86E1-4083-8F42-2F15339AF1FBQ47593693-571D12C3-3E3F-46FA-9F9F-8CD72DED5C32Q48141250-05A647FA-ED97-4247-8804-D240A3AF975AQ49516622-349B6880-74D3-4F56-9D93-DE1DFB2343F5Q52143402-E969069B-B360-4263-ADC8-F381A8391BBCQ52147613-870AE0F0-B239-4B35-93D3-10C013554065Q52332793-26E6623B-A9CC-4650-9835-81BBBBD315D5Q54434473-3461B66A-1B78-4E6F-8305-C0E24C5EDA40Q55378559-097786EE-B679-4556-931F-0D76A47BB033
P2860
Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Increased expression of caspas ...... ients with multiple sclerosis.
@en
type
label
Increased expression of caspas ...... ients with multiple sclerosis.
@en
prefLabel
Increased expression of caspas ...... ients with multiple sclerosis.
@en
P2093
P1476
Increased expression of caspas ...... ients with multiple sclerosis.
@en
P2093
Jan Hillert
Ping Huang
Wen-Xin Huang
P304
P356
10.1191/1352458504MS1071OA
P577
2004-10-01T00:00:00Z